Rapid Review Quiz: Pneumococcal Infections

Michael Stuart Bronze, MD

Disclosures

March 11, 2022

To simplify practice, the ACIP now recommends either PCV15 followed by a dose of PPSV23, typically ≥ 1 year later, or PCV20; these vaccines can be used in PCV-naive adults aged ≥ 65 years or those aged 19-64 years with certain underlying conditions. Under the previous guidelines, recommendations for use of the PCV13 and PPSV23 varied by age and risk group.

Learn more about 15-valent and 20-valent vaccines.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

processing....